Veri MedTech Holdings, Inc. Form S-1/A — Sep 22, 2026
Veri Medtech Holdings (VRHI) filed an S-1/A for a firm-commitment IPO of up to 3,750,000 shares at an assumed $4.00 per share, targeting roughly $15M gross and ~$11.9M net proceeds after a 7% underwriting discount, 2% corporate finance fee, and other expenses. The stock, currently on the OTCID market, is contingent on approval for NASDAQ Capital Market listing, and the company also granted the underwriter warrants for 5% of shares sold at $4.80 plus a 562,500-share over-allotment option.
Key figures
- Gross Proceeds
- 15000000
- Offering Price
- 4
- Shares Offered
- 3750000
- Shares Outstanding
- 11750004
- Employees
- 25
- Lockup days
- 180
- Fy2024 revenue
- 17000000
- Fy2025 revenue
- 11000000
- Otc last price
- 5
- Fy2024 net loss
- 409000
- Fy2025 net loss
- 2320000
- Q2 2026 revenue 3mo
- 2043000
- Reverse split ratio
- 1-for-2.5
- Six mo 2026 revenue
- 4480000
- Q2 2026 net loss 3mo
- 296000
- Six mo 2026 net loss
- 496000
- Over allotment shares
- 562500
- Buyback shares authorized
- 3000000
- Corporate finance fee pct
- 2%
- Underwriting discount pct
- 7%
- Representative warrant strike
- 4.8
- Representative warrants shares
- 187500
- Pre offering shares outstanding
- 8000004
- Series a preferred voting power
- 80%
AI analysis
Red flags9 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.